Alignment Healthcare Reports Strong Q1 Earnings Amid Market Gains
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 28 2026
0mins
Should l Buy ALHC?
Source: PRnewswire
Alignment Healthcare's stock fell 11.93% and hit a 5-day low despite the broader market's positive performance, with the Nasdaq-100 up 0.90% and the S&P 500 up 0.62%.
The company reported a Q1 GAAP EPS of $0.05, beating expectations by $0.04, and achieved revenue of $1.23 billion, a 32.7% year-over-year increase. This strong earnings performance reflects robust growth in the Medicare market and demonstrates ongoing improvements in profitability, which has boosted investor confidence. Additionally, the CFO raised the 2026 membership guidance, indicating continued growth prospects.
Despite the stock's decline, the strong financial results and optimistic outlook suggest that Alignment Healthcare is well-positioned for future growth, although market sentiment may have shifted focus away from the stock in the short term.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ALHC?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ALHC
Wall Street analysts forecast ALHC stock price to rise
9 Analyst Rating
7 Buy
2 Hold
0 Sell
Strong Buy
Current: 18.140
Low
18.00
Averages
21.81
High
30.00
Current: 18.140
Low
18.00
Averages
21.81
High
30.00
About ALHC
Alignment Healthcare, Inc. is a consumer-centric platform designed to improve the healthcare experience for seniors. The Company’s operations primarily consist of Medicare Advantage Plans in the states of California, North Carolina, Nevada, Arizona, Florida and Texas. It partners with local providers to deliver coordinated care, powered by its customized care model, 24/7 concierge care team and purpose-built technology (AVA). AVA’s capabilities include consumer experience, internal care delivery, external providers, health plan operations and growth operations. AVA offers a digital ecosystem that enables its members and their support system to get the information and care they need, when and how they need it. With their AVA-powered member portal and mobile app, seniors have many self-service capabilities and can get 24/7 care, send secure messages to their concierge and care teams, check their rewards and ACCESS On-Demand Concierge Card balance, and view their health history.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Alignment Healthcare Q1 2026 Earnings Call Insights
- Significant Membership Growth: Alignment Healthcare reported a health plan membership of 284,800 in Q1, representing a year-over-year growth of approximately 31%, indicating enhanced market appeal and customer retention capabilities, which are expected to drive future revenue growth.
- Financial Performance Exceeds Expectations: The company achieved total revenue of $1.2 billion in Q1, with adjusted gross profit of $146 million and adjusted EBITDA of $38 million, all surpassing the high end of the company's guidance range, demonstrating ongoing improvements in profitability.
- Operational Efficiency Improvement: The auto adjudication rate increased from less than 15% a year ago to over 60%, driven by the deployment of AI-powered contract management solutions, which is expected to further reduce costs and enhance profit margins.
- Optimistic Outlook: The CFO raised the 2026 membership guidance to 294,000-299,000 and projected Q2 revenue between $1.30 billion and $1.32 billion, reflecting strong performance in sales and customer retention, signaling continued growth prospects.
See More
Alignment Healthcare Q1 Earnings Beat Expectations
- Strong Earnings Performance: Alignment Healthcare reported a Q1 GAAP EPS of $0.05, beating expectations by $0.04, indicating a significant improvement in profitability and reflecting robust performance in the Medicare market.
- Significant Revenue Growth: The company achieved revenue of $1.23 billion, a 32.7% year-over-year increase, surpassing market expectations by $10 million, demonstrating ongoing business expansion and a growing customer base that enhances market competitiveness.
- Improved Adjusted Gross Profit: Adjusted gross profit reached $145.9 million, up 36.1% year-over-year, with operating income at $15.5 million, showcasing the company's success in cost control and efficiency improvements, further solidifying its financial health.
- Net Income Turnaround: The net income of $11.4 million marked a significant improvement from a net loss of $9.4 million in the prior year, indicating ongoing progress in profitability and operational efficiency, which boosts investor confidence.
See More
Investment Opportunities in Small-Cap Stocks
- Hope Bancorp's Flat Performance: Hope Bancorp (HOPE), with a market cap of $1.61 billion, has seen stagnant net interest income and earnings per share over the past five years, indicating a failure to expand within its diverse customer base, necessitating new strategies to enhance shareholder value.
- Fluence Energy's Strong Growth: Fluence Energy (FLNC), valued at $1.79 billion, boasts an impressive annual revenue growth rate of 33.8% over the past five years, with earnings per share growing at 36.4% annually, showcasing its robust competitive position in the lithium-ion battery storage market, despite still negative free cash flow margins that are improving.
- Alignment Healthcare's Rapid Expansion: Alignment Healthcare (ALHC), with a market cap of $4.26 billion, has achieved a remarkable 47.1% annual revenue growth over the last two years and a 27.7% annual increase in earnings per share, indicating significant market share gains in the Medicare Advantage sector, with positive free cash flow now reflecting a pivotal moment for the company.
- Challenges in Small-Cap Market: While small-cap stocks within the Russell 2000 index face greater instability and resource constraints, careful analysis and selection can uncover high-return opportunities, particularly in rapidly growing sectors, making it essential for investors to navigate this market wisely.
See More
Analysis of Alignment Healthcare Executive Stock Transaction
- Transaction Overview: Dawn Christine Maroney, President of Alignment Healthcare, sold 30,000 shares of common stock on April 15, 2026, for a total value of $626,199, leaving her with 1,028,813 shares valued at approximately $21.5 million, indicating her ongoing engagement in the market.
- Trading Pattern Analysis: This sale aligns with Maroney's established monthly selling pattern and is below her historical average of 63,700 shares per sale, reflecting a trend of reduced holdings that may influence investor confidence.
- Shareholder Alignment: Post-transaction, Maroney retains about 0.50% ownership, ensuring alignment with shareholders and indicating her sustained confidence in the company's future prospects.
- Future Performance Outlook: Alignment Healthcare projects 2026 revenue between $5.14 billion and $5.19 billion, representing a 30% to 31% increase from the previous year, showcasing the company's positive trajectory in improving profitability and competitive positioning.
See More
Alignment CEO Sells 250,000 Shares
- Executive Share Sale: On April 7, 2026, Alignment's CEO John E Kao sold 250,000 shares, which may indicate a cautious outlook on the company's future performance, potentially negatively impacting investor confidence.
- Market Reaction Anticipation: Such executive sell-offs often lead to speculation regarding internal company information, causing investors to question Alignment's future performance, which could result in stock price volatility.
- Shareholding Structure Shift: This sale may prompt a reassessment of Alignment's shareholding structure in the market, particularly in light of executive sell-offs, raising concerns about corporate governance and transparency.
- Investor Confidence Challenge: Kao's sale could lead investors to doubt the company's long-term strategy and growth prospects, especially in the current market environment, potentially affecting the company's ability to raise funds and deliver shareholder returns.
See More
Alignment Healthcare Shares Surge 16.01% on Medicare Rate Increase
- Policy Boost: Alignment Healthcare's stock surged 16.01% on Tuesday, closing at $21.66 per share, as investors celebrated the higher reimbursement rates for Medicare Advantage plans, expected to yield over $13 billion in additional payments.
- Significant Rate Increase: The Centers for Medicare & Medicaid Services (CMS) reported a net average increase of 2.48% for next year's Medicare Advantage policies, a substantial rise from the 0.09% announced in January, which will directly impact the company's revenue growth.
- Optimistic Financial Outlook: Alignment Healthcare anticipates reporting first-quarter earnings with revenue targets between $5.135 billion and $5.190 billion, alongside health plan membership projections of 292,000 to 298,000, indicating robust growth potential in the market.
- Market Competition Insight: While there is optimism regarding ALHC as an investment, analysts suggest that certain AI stocks may offer greater upside potential and lower downside risk, reflecting a diverse focus on various investment opportunities in the market.
See More
Alignment Healthcare Q1 2026 Earnings Call Insights
- Significant Membership Growth: Alignment Healthcare reported a health plan membership of 284,800 in Q1, representing a year-over-year growth of approximately 31%, indicating enhanced market appeal and customer retention capabilities, which are expected to drive future revenue growth.
- Financial Performance Exceeds Expectations: The company achieved total revenue of $1.2 billion in Q1, with adjusted gross profit of $146 million and adjusted EBITDA of $38 million, all surpassing the high end of the company's guidance range, demonstrating ongoing improvements in profitability.
- Operational Efficiency Improvement: The auto adjudication rate increased from less than 15% a year ago to over 60%, driven by the deployment of AI-powered contract management solutions, which is expected to further reduce costs and enhance profit margins.
- Optimistic Outlook: The CFO raised the 2026 membership guidance to 294,000-299,000 and projected Q2 revenue between $1.30 billion and $1.32 billion, reflecting strong performance in sales and customer retention, signaling continued growth prospects.
See More
Alignment Healthcare Q1 Earnings Beat Expectations
- Strong Earnings Performance: Alignment Healthcare reported a Q1 GAAP EPS of $0.05, beating expectations by $0.04, indicating a significant improvement in profitability and reflecting robust performance in the Medicare market.
- Significant Revenue Growth: The company achieved revenue of $1.23 billion, a 32.7% year-over-year increase, surpassing market expectations by $10 million, demonstrating ongoing business expansion and a growing customer base that enhances market competitiveness.
- Improved Adjusted Gross Profit: Adjusted gross profit reached $145.9 million, up 36.1% year-over-year, with operating income at $15.5 million, showcasing the company's success in cost control and efficiency improvements, further solidifying its financial health.
- Net Income Turnaround: The net income of $11.4 million marked a significant improvement from a net loss of $9.4 million in the prior year, indicating ongoing progress in profitability and operational efficiency, which boosts investor confidence.
See More
Investment Opportunities in Small-Cap Stocks
- Hope Bancorp's Flat Performance: Hope Bancorp (HOPE), with a market cap of $1.61 billion, has seen stagnant net interest income and earnings per share over the past five years, indicating a failure to expand within its diverse customer base, necessitating new strategies to enhance shareholder value.
- Fluence Energy's Strong Growth: Fluence Energy (FLNC), valued at $1.79 billion, boasts an impressive annual revenue growth rate of 33.8% over the past five years, with earnings per share growing at 36.4% annually, showcasing its robust competitive position in the lithium-ion battery storage market, despite still negative free cash flow margins that are improving.
- Alignment Healthcare's Rapid Expansion: Alignment Healthcare (ALHC), with a market cap of $4.26 billion, has achieved a remarkable 47.1% annual revenue growth over the last two years and a 27.7% annual increase in earnings per share, indicating significant market share gains in the Medicare Advantage sector, with positive free cash flow now reflecting a pivotal moment for the company.
- Challenges in Small-Cap Market: While small-cap stocks within the Russell 2000 index face greater instability and resource constraints, careful analysis and selection can uncover high-return opportunities, particularly in rapidly growing sectors, making it essential for investors to navigate this market wisely.
See More
Analysis of Alignment Healthcare Executive Stock Transaction
- Transaction Overview: Dawn Christine Maroney, President of Alignment Healthcare, sold 30,000 shares of common stock on April 15, 2026, for a total value of $626,199, leaving her with 1,028,813 shares valued at approximately $21.5 million, indicating her ongoing engagement in the market.
- Trading Pattern Analysis: This sale aligns with Maroney's established monthly selling pattern and is below her historical average of 63,700 shares per sale, reflecting a trend of reduced holdings that may influence investor confidence.
- Shareholder Alignment: Post-transaction, Maroney retains about 0.50% ownership, ensuring alignment with shareholders and indicating her sustained confidence in the company's future prospects.
- Future Performance Outlook: Alignment Healthcare projects 2026 revenue between $5.14 billion and $5.19 billion, representing a 30% to 31% increase from the previous year, showcasing the company's positive trajectory in improving profitability and competitive positioning.
See More
Alignment CEO Sells 250,000 Shares
- Executive Share Sale: On April 7, 2026, Alignment's CEO John E Kao sold 250,000 shares, which may indicate a cautious outlook on the company's future performance, potentially negatively impacting investor confidence.
- Market Reaction Anticipation: Such executive sell-offs often lead to speculation regarding internal company information, causing investors to question Alignment's future performance, which could result in stock price volatility.
- Shareholding Structure Shift: This sale may prompt a reassessment of Alignment's shareholding structure in the market, particularly in light of executive sell-offs, raising concerns about corporate governance and transparency.
- Investor Confidence Challenge: Kao's sale could lead investors to doubt the company's long-term strategy and growth prospects, especially in the current market environment, potentially affecting the company's ability to raise funds and deliver shareholder returns.
See More
Alignment Healthcare Shares Surge 16.01% on Medicare Rate Increase
- Policy Boost: Alignment Healthcare's stock surged 16.01% on Tuesday, closing at $21.66 per share, as investors celebrated the higher reimbursement rates for Medicare Advantage plans, expected to yield over $13 billion in additional payments.
- Significant Rate Increase: The Centers for Medicare & Medicaid Services (CMS) reported a net average increase of 2.48% for next year's Medicare Advantage policies, a substantial rise from the 0.09% announced in January, which will directly impact the company's revenue growth.
- Optimistic Financial Outlook: Alignment Healthcare anticipates reporting first-quarter earnings with revenue targets between $5.135 billion and $5.190 billion, alongside health plan membership projections of 292,000 to 298,000, indicating robust growth potential in the market.
- Market Competition Insight: While there is optimism regarding ALHC as an investment, analysts suggest that certain AI stocks may offer greater upside potential and lower downside risk, reflecting a diverse focus on various investment opportunities in the market.
See More
